Concept-to-Commercialization: Thermo Fisher's Unique Approach to Rapidly Advancing Antibody and Protein Therapeutics

Explore Thermo Fisher's innovative approach to accelerating antibody and protein therapeutics development in this 69-minute panel presentation. Learn how the company speeds up development timelines by beginning with gene optimization and transient protein expression and purification pilots. Discover their integrated workflow for swiftly progressing from R&D and pre-clinical pilots to first-in-human (FIH) trials. Presented by Steve Lewis, who leads a global DNA and protein biomanufacturing product portfolio at Thermo Fisher Scientific, and Dr. Jeff Hou, who supports Global Sales and Business Development teams in biologics manufacturing. Gain valuable insights into cutting-edge strategies for advancing therapeutic development in this informative webinar hosted by Labroots.